Cytoplasmic levels of high mobility group A2 determine survival prognoses in breast cancer patients.
Heilmann T, Vondung F, Borzikowsky C, Krüger S, Elessawy M, Alkatout I, Wenners A, Bauer M, Klapper W, Röcken C, Maass N, Schem C, Trauzold A.
Heilmann T, et al. Among authors: kruger s.
Int J Biol Markers. 2020 Jun;35(2):20-28. doi: 10.1177/1724600820917990. Epub 2020 May 12.
Int J Biol Markers. 2020.
PMID: 32394766
Free article.